Clinical trials in Bellflower, CA

17 recruiting studies have a site in or near Bellflower, CA, California.

Top conditions here

All conditions

Showing 17 of 17 studies

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1147 more sites

RecruitingPhase 4NCT07221877

A Study to Evaluate the Effect of KarXT on Urological Safety

Sponsor: Bristol-Myers Squibb

Bellflower, CA · Garden Grove, CA · Orange, CA · +13 more sites

RecruitingPhase 2NCT07459647

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Sponsor: MapLight Therapeutics

Bellflower, CA · Cerritos, CA · Culver City, CA · +42 more sites

RecruitingPhase 2NCT07610473

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Sponsor: Draig Therapeutics Ltd

Bellflower, CA · Costa Mesa, CA · Lafayette, CA · +20 more sites

RecruitingPhase 3NCT07484217

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Sponsor: Axsome Therapeutics, Inc.

Bellflower, CA · Chino, CA · Glendale, CA · +37 more sites

RecruitingPhase 2NCT06031688

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Auburn, CA · Baldwin Park, CA · +275 more sites

RecruitingPhase 2NCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

Sponsor: Eli Lilly and Company

Bellflower, CA · Garden Grove, CA · Montclair, CA · +29 more sites

RecruitingPhase 3NCT07686263

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Anaheim, CA · Bellflower, CA · Chino, CA · +31 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1223 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Bakersfield, CA · +378 more sites

RecruitingPhase 3NCT07565428

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Sponsor: Minerva Neurosciences

Bellflower, CA · Culver City, CA · Garden Grove, CA · +10 more sites

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Anaheim, CA · Arroyo Grande, CA · Baldwin Park, CA · +371 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Arroyo Grande, CA · +451 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1226 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +809 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Arroyo Grande, CA · +952 more sites

Not yet recruitingPhase 4NCT06924255

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

Sponsor: Collaborative Neuroscience Research, LLC

Bellflower, CA · Garden Grove, CA · Riverside, CA · +4 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.